• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Research Solutions Reports Fiscal Second Quarter 2024 Results

    2/8/24 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology
    Get the next $RSSS alert in real time by email

    Reports 18.3% Revenue Increase and ARR of $15.6 Million

    HENDERSON, Nev., Feb. 8, 2024 /PRNewswire/ --Research Solutions, Inc. (NASDAQ:RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, reported financial results for its fiscal second quarter ended December 31, 2023.

    (PRNewsfoto/Research Solutions, Inc.)

    Fiscal Second Quarter 2024 Summary

    • Total revenue of $10.3 million, an 18.3% increase from the prior-year quarter
    • Platform revenue up 48% to $3.1 million. Annual Recurring Revenue ("ARR") up 77% to $15.6 million, which includes approximately $4.0 million of B2C recurring revenue and $0.4M of B2B recurring revenue from the Scite, Inc. ("Scite") acquisition.  B2C ARR is broken out on a separate line in the Company's Financial and Operational Summary Tables and for the purposes of calculating B2C ARR, the value of any monthly recurring subscriptions has been multiplied by twelve (see the Financial and Operational Summary Tables and associated notes below).
    • Gross profit up 31.7% from the prior-year quarter. Total gross margin improved 450 basis points to 43.5%.
    • Net loss of $54,000 or ($0.00) on a per share basis, compared to a net loss of ($256,000) or ($0.01) per share in the prior-year quarter. The quarter's loss includes $307,000 in expenses related to M&A activities, most of which were legal expenses.
    • Adjusted EBITDA of $318,000 compared to $201,000 in the prior-year quarter.  The Adjusted EBITDA result is inclusive of the expenses related to M&A activities noted above.  Without these costs, Adjusted EBITDA would have been approximately $625,000.
    • The company closed its acquisition of Scite on December 1, 2023. The quarter's numbers include approximately one month of activity from Scite.

    "Our second quarter results reflect the continued execution of our plan and with the acquisition of Scite our ARR is now approximately $15.6 million.  We also experienced continued organic growth across our platform and transaction offerings, with net incremental ARR on the Article Galaxy platform being our best result in the last four quarters," said Roy W. Olivier, President and CEO of Research Solutions. "In addition, we have greatly enhanced the offerings available within our Article Galaxy platform over the past six months with the addition of ResoluteAI and Scite. When combined with our existing products, these acquisitions add multiple new workflow and advanced search and discovery solutions that can be sold to new or existing customers.  These new solutions materially increase our Total Addressable Market ("TAM") and as we further integrate the products together, we will be able to deliver unique value to our customers. Overall, we remain a critical piece of the research process and believe we are well-positioned to expand our user base as macroeconomic conditions improve." 

    Fiscal Second Quarter 2024 Results

    Total revenue was $10.3 million, an 18% increase from $8.7 million in the year-ago quarter as both platform and transaction revenue increased from the prior-year period.

    Platform subscription revenue increased 48% to $3.1 million compared to $2.1 million in the year-ago quarter. The increase was primarily due to the acquisitions of ResoluteAI and Scite, as well as organic growth in the core Article Galaxy platform. The quarter ended with annual recurring revenue of $15.569 million, up 77% year-over-year, including approximately $4.355 million of ARR from Scite (see the company's definition of annual recurring revenue below).

    Transaction revenue was $7.2 million, compared to $6.6 million in the second quarter of fiscal 2023. The increase was primarily due to organic growth, which was also enhanced by higher transaction volumes related to contracts transferred from FIZ Karlsruhe effective on January 1, 2023. The transaction customer count for the quarter was 1,398, compared to 1,223 customers in the prior-year quarter (see the company's definition of active customer accounts and transactions below).

    Total gross margin improved 450 basis points from the prior-year quarter to 43.5%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business, as well as increased margins in the transactions business.

    Total operating expenses were $4.9 million, compared to $3.7 million in the second quarter of 2023. The increase was primarily related to the additional expense base associated with the acquisitions of ResoluteAI and Scite.  Additionally, this quarter's results include $307,000 in expenses related to M&A activities, the vast majority of which were legal expenses.

    Net loss in the second quarter was $54,000, or roughly breakeven on a per share basis, compared to a net loss of ($256,000), or ($0.01) per share, in the prior-year quarter. Adjusted EBITDA was $318,000, compared to $201,000 in the year-ago quarter.  The Adjusted EBITDA result is inclusive of the $307,000 in M&A activity related costs noted above (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

    Conference Call

    Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.

    Date: Thursday, February 8, 2024

    Time: 5:00 p.m. ET (2:00 p.m. PT)

    Dial-in number: 1-412-317-5180

    Conference ID: 10185927

    The conference call will be broadcast live and available for replay until March 8, 2024 by dialing  1-412-317-6671 and using the replay ID 10185927, and via the investor relations section of the company's website at http://researchsolutions.investorroom.com/.

    Fiscal Second Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter





    Quarter Ended December 31,



    Fiscal Year Ended December 31,





    2023

    2022

    Change

    % Change



    2023

    2022

    Change

    % Change

    Revenue:





















    Platforms

    $   3,125,584

    $ 2,110,272

    $  1,015,312

    48.1 %



    $   5,725,776

    $   4,130,239

    $  1,595,537

    38.6 %



    Transactions

    $   7,188,158

    $ 6,606,394

    581,764

    8.8 %



    $ 14,648,937

    $ 13,271,070

    1,377,867

    10.4 %

    Total Revenue

    10,313,742

    8,716,666

    1,597,076

    18.3 %



    20,374,713

    17,401,309

    2,973,404

    17.1 %





















    Gross Profit:





















    Platforms

    2,639,399

    1,857,199

    782,200

    42.1 %



    4,856,977

    3,646,693

    1,210,284

    33.2 %



    Transactions

    1,844,403

    1,546,628

    297,775

    19.3 %



    3,658,391

    3,106,382

    552,009

    17.8 %

    Total Gross Profit

    4,483,802

    3,403,827

    1,079,975

    31.7 %



    8,515,368

    6,753,075

    1,762,293

    26.1 %





















    Gross profit as a % of revenue:





















    Platforms

    84.4 %

    88.0 %

    -3.6 %





    84.8 %

    88.3 %

    -3.5 %





    Transactions

    25.7 %

    23.4 %

    2.2 %





    25.0 %

    23.4 %

    1.6 %



    Total Gross Profit

    43.5 %

    39.0 %

    4.4 %





    41.8 %

    38.8 %

    3.0 %























    Operating Expenses:





















    Sales and marketing

    804,927

    666,608

    138,319

    20.7 %



    1,489,943

    1,187,824

    302,119

    25.4 %



    Technology and product development

    1,336,558

    922,132

    414,426

    44.9 %



    2,581,137

    1,797,422

    783,715

    43.6 %



    General and administrative

    2,023,848

    1,613,664

    410,184

    25.4 %



    4,566,717

    3,133,088

    1,433,629

    45.8 %



    Depreciation and amortization

    155,749

    6,342

    149,407

    2355.8 %



    215,369

    12,154

    203,215

    1672.0 %



    Stock-based compensation

    596,455

    608,703

    (12,248)

    -2.0 %



    1,188,269

    784,064

    404,205

    51.6 %



    Foreign currency translation loss

    (13,738)

    (84,179)

    70,441

    83.7 %



    (7,118)

    (11,663)

    4,545

    39.0 %

    Total Operating Expenses

    4,903,799

    3,733,270

    1,170,529

    31.4 %



    10,034,317

    6,902,889

    3,131,428

    45.4 %

    Income (loss) from operations

    (419,997)

    (329,443)

    (90,554)

    -27.5 %



    (1,518,949)

    (149,814)

    (1,369,135)

    -913.9 %





















    Other Income (Expenses):





















    Other income

    376,426

    74,695

    301,731

    404.0 %



    516,737

    113,764

    402,973

    354.2 %



    Provision for income taxes

    (10,057)

    (782)

    (9,275)

    1186.1 %



    (39,459)

    (4,915)

    (34,544)

    702.8 %

    Total Other Income (Expenses):

    366,369

    73,913

    292,456

    395.7 %



    477,278

    108,849

    368,429

    338.5 %

    Net income (loss)

    $       (53,628)

    $   (255,530)

    201,902

    79.0 %



    $  (1,041,671)

    $       (40,965)

    (1,000,706)

    -2442.8 %



















    NM

    Adjusted EBITDA

    $       318,469

    $     201,423

    $      117,046

    58.1 %



    $     (122,429)

    $       634,741

    $    (757,170)

    NM



























    Quarter Ended December 31,



    Fiscal Year Ended December 31,





    2023

    2022

    Change

    % Change



    2023

    2022

    Change

    % Change

    Platforms:





















    B2B ARR (Annual recurring revenue):





















      Beginning of Period

    $ 11,020,241

    $ 8,331,770

    $  2,688,471

    32.3 %



    $   9,444,130

    $   7,922,188

    $  1,521,942

    19.2 %



       Incremental ARR

    594,507

    445,207

    149,300

    33.5 %



    2,170,618

    854,789

    1,315,829

    153.9 %



      End of Period

    $ 11,614,748

    $ 8,776,977

    $  2,837,771

    32.3 %



    $ 11,614,748

    $   8,776,977

    $  2,837,771

    32.3 %























    Deployments:





















      Beginning of Period

    880

    756

    124

    16.4 %



    835

    733

    102

    13.9 %



       Incremental Deployments

    62

    34

    28

    82.4 %



    107

    57

    50

    87.7 %



      End of Period

    942

    790

    152

    19.2 %



    942

    790

    152

    19.2 %























    ASP (Average sales price):





















      Beginning of Period

    $         12,523

    $       11,021

    $          1,502

    13.6 %



    $         11,310

    $         10,808

    $              502

    4.6 %



      End of Period

    $         12,330

    $       11,110

    $          1,220

    11.0 %



    $         12,330

    $         11,110

    $          1,220

    11.0 %

























    B2C ARR (Annual recurring revenue):





















      Beginning of Period

    $                  -

    $                -

    $                 -





    $                  -

    $                  -

    $                 -





       Incremental ARR

    3,954,090

    -

    3,954,090

    NM



    3,954,090

    -

    3,954,090

    NM



      End of Period

    $   3,954,090

    $                -

    $  3,954,090

    NM



    $   3,954,090

    $                  -

    $  3,954,090

    NM

























    Total ARR (Annualized recurring revenue):

    $ 15,568,838

    $ 8,776,977

    $  6,791,861

    77.4 %



    $ 15,568,838

    $   8,776,977

    $  6,791,861

    77.4 %























    Transaction Customers:





















    Corporate customers

    1,065

    921

    144

    15.6 %



    1,078

    922

    157

    17.0 %



    Academic customers

    333

    302

    31

    10.3 %



    319

    300

    19

    6.3 %



    Total customers

    1,398

    1,223

    175

    14.3 %



    1,397

    1,222

    176

    14.4 %

    Active Customer Accounts, Transactions and Annual Recurring Revenue

    The company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

    A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

    The company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period.  For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.

    Use of Non-GAAP Measure – Adjusted EBITDA

    Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the company's operating results.

    The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other income (expense), foreign currency transaction loss, provision for income taxes, depreciation and amortization, stock-based compensation, gain on sale of discontinued operations, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):





    Quarter Ended December 31,



    Fiscal Year Ended December 31,





    2023

    2022

    Change

    % Change



    2023

    2022

    Change

    % Change

    Net Income (loss)

    $       (53,628)

    $   (255,530)

    $      201,902

    79.0 %



    $  (1,041,671)

    $       (40,965)

    $ (1,000,706)

    -2442.8 %

     Add (deduct):















    -





    Other income (expense)

    (376,426)

    (74,695)

    (301,731)

    404.0 %



    (516,737)

    (113,764)

    (402,973)

    354.2 %



    Foreign currency translation loss

    (13,738)

    (84,179)

    70,441

    83.7 %



    (7,118)

    (11,663)

    4,545

    39.0 %



    Provision for income taxes

    10,057

    782

    9,275

    1186.1 %



    39,459

    4,915

    34,544

    702.8 %



    Depreciation and amortization

    155,749

    6,342

    149,407

    2355.8 %



    215,369

    12,154

    203,215

    1672.0 %



    Stock-based compensation

    596,455

    608,703

    (12,248)

    -2.0 %



    1,188,269

    784,064

    404,205

    51.6 %



    Gain on sale of disc. ops.

    -

    -

    -





    -

    -

    -



     Adjusted EBITDA

    $       318,469

    $     201,423

    $      117,046

    58.1 %



    $     (122,429)

    $       634,741

    $    (757,170)

    NM

    About Research Solutions 

    Research Solutions, Inc. (NASDAQ:RSSS) provides cloud-based technologies to streamline the process of obtaining, managing, and creating intellectual property. Founded in 2006 as Reprints Desk, the company was a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on Article Galaxy, the company's SaaS research platform, to streamline access to the latest scientific research and data with 24/7 customer support. For more information and details, please visit www.researchsolutions.com 

    Important Cautions Regarding Forward-Looking Statements

    Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission. 

     

    Research Solutions, Inc. and Subsidiaries

    Consolidated Balance Sheets







    December 31, 













    2023



    June 30, 







    (unaudited)



    2023



    Assets















    Current assets:















    Cash and cash equivalents



    $

    2,697,659



    $

    13,545,333



    Accounts receivable, net of allowance of $94,991 and $85,015, respectively





    7,289,248





    6,153,063



    Prepaid expenses and other current assets





    547,786





    400,340



    Prepaid royalties





    1,081,578





    1,202,678



    Total current assets





    11,616,271





    21,301,414



















    Goodwill (provisional)





    16,451,937





    —



















    Other assets:















    Property and equipment, net of accumulated depreciation of $905,411 and $881,908, respectively





    103,195





    70,193



    Intangible assets, net of accumulated amortization of $940,234 and $747,355, respectively

    ($10,806,487 provisional)





    11,290,225





    462,068



    Deposits and other assets





    1,060





    1,052



    Total assets



    $

    39,462,688



    $

    21,834,727



















    Liabilities and Stockholders' Equity















    Current liabilities:















    Accounts payable and accrued expenses



    $

    8,862,829



    $

    8,079,516



    Deferred revenue





    7,843,674





    6,424,724



    Total current liabilities





    16,706,503





    14,504,240



















    Long-term liabilities:















    Contingent earnout liability





    8,792,811





    —



    Total liabilities





    25,499,314





    14,504,240



















    Commitments and contingencies































    Stockholders' equity:















    Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding





    —





    —



    Common stock; $0.001 par value; 100,000,000 shares authorized; 32,619,598 and

    29,487,508 shares issued and outstanding, respectively





    32,620





    29,487



    Additional paid-in capital





    37,607,895





    29,941,873



    Accumulated deficit





    (23,564,320)





    (22,522,649)



    Accumulated other comprehensive loss





    (112,821)





    (118,224)



    Total stockholders' equity





    13,963,374





    7,330,487



    Total liabilities and stockholders' equity



    $

    39,462,688



    $

    21,834,727



     

    Research Solutions, Inc. and Subsidiaries

    Consolidated Statements of Operations and Other Comprehensive Loss

    (Unaudited)







    Three Months Ended



    Six Months Ended







    December 31, 



    December 31, 







    2023



    2022



    2023



    2022































    Revenue:



























    Platforms



    $

    3,125,584



    $

    2,110,272



    $

    5,725,776



    $

    4,130,239



    Transactions





    7,188,158





    6,606,394





    14,648,937





    13,271,070



    Total revenue





    10,313,742





    8,716,666





    20,374,713





    17,401,309































    Cost of revenue:



























    Platforms





    486,185





    253,073





    868,799





    483,546



    Transactions





    5,343,755





    5,059,766





    10,990,546





    10,164,688



    Total cost of revenue





    5,829,940





    5,312,839





    11,859,345





    10,648,234



    Gross profit





    4,483,802





    3,403,827





    8,515,368





    6,753,075































    Operating expenses:



























    Selling, general and administrative





    4,748,050





    3,726,928





    9,818,948





    6,890,735



    Depreciation and amortization





    155,749





    6,342





    215,369





    12,154



    Total operating expenses





    4,903,799





    3,733,270





    10,034,317





    6,902,889































    Loss from operations





    (419,997)





    (329,443)





    (1,518,949)





    (149,814)































    Other income





    376,426





    74,695





    516,737





    113,764































    Loss from operations before provision for income taxes





    (43,571)





    (254,748)





    (1,002,212)





    (36,050)



    Provision for income taxes





    (10,057)





    (782)





    (39,459)





    (4,915)































    Net loss





    (53,628)





    (255,530)





    (1,041,671)





    (40,965)































    Other comprehensive income (loss):



























    Foreign currency translation





    6,349





    6,524





    5,403





    1,348



    Comprehensive loss



    $

    (47,279)



    $

    (249,006)



    $

    (1,036,268)



    $

    (39,617)































    Loss per common share:



























    Net loss per share, basic and diluted



    $

    -



    $

    (0.01)



    $

    (0.04)



    $

    -



    Weighted average common shares outstanding, basic and diluted





    28,092,945





    26,816,550





    27,564,404





    26,767,360



     

    Research Solutions, Inc. and Subsidiaries

    Consolidated Statements of Cash Flows

    (Unaudited)







    Six Months Ended







    December 31, 







    2023



    2022



















    Cash flow from operating activities:















    Net loss



    $

    (1,041,671)



    $

    (40,965)



    Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities:















    Depreciation and amortization





    215,369





    12,154



    Fair value of vested stock options





    61,714





    301,737



    Fair value of vested restricted common stock





    1,105,606





    482,327



    Fair value of vested unrestricted common stock





    —





    68,272



    Modification cost of accelerated vesting of restricted common stock





    20,949





    —



    Changes in operating assets and liabilities:















    Accounts receivable





    (681,502)





    8,159



    Prepaid expenses and other current assets





    (67,986)





    (67,603)



    Prepaid royalties





    121,100





    805,436



    Accounts payable and accrued expenses





    81,078





    (974,931)



    Deferred revenue





    (241,545)





    428,999



    Net cash provided by (used in) operating activities





    (426,888)





    1,023,585



















    Cash flow from investing activities:















    Purchase of property and equipment





    (55,763)





    (18,876)



    Payment for acquisition of Resolute, net of cash acquired





    (2,718,253)





    —



    Payment for acquisition of Scite, net of cash acquired





    (7,305,493)





    —



    Payment for non-refundable deposit for asset acquisition





    —





    (297,450)



    Net cash used in investing activities





    (10,079,509)





    (316,326)



















    Cash flow from financing activities:















    Common stock repurchase





    (68,748)





    (48,729)



    Payment of contingent acquisition consideration





    (278,195)





    —



    Net cash used in financing activities





    (346,943)





    (48,729)



















    Effect of exchange rate changes





    5,666





    859



    Net increase (decrease) in cash and cash equivalents





    (10,847,674)





    659,389



    Cash and cash equivalents, beginning of period





    13,545,333





    10,603,175



    Cash and cash equivalents, end of period



    $

    2,697,659



    $

    11,262,564



















    Supplemental disclosures of cash flow information:















    Cash paid for income taxes



    $

    39,459



    $

    4,915



















    Non-cash investing and financing activities:















    Contingent consideration accrual on asset acquisition



    $

    36,364



    $

    —



     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-fiscal-second-quarter-2024-results-302057973.html

    SOURCE Research Solutions, Inc.

    Get the next $RSSS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RSSS

    DatePrice TargetRatingAnalyst
    6/30/2021$4.34Buy
    Roth Capital
    More analyst ratings

    $RSSS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on Research Solutions with a new price target

    Roth Capital initiated coverage of Research Solutions with a rating of Buy and set a new price target of $4.35

    6/30/21 8:31:03 AM ET
    $RSSS
    EDP Services
    Technology

    Maxim Group initiated coverage on Research Solutions with a new price target

    Maxim Group initiated coverage of Research Solutions with a rating of Buy and set a new price target of $6.00

    6/18/21 8:32:12 AM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Leadership Updates

    Live Leadership Updates

    View All

    Research Solutions Appoints Sefton Cohen as Chief Revenue Officer

    SaaS Executive with Track Record of Accelerating Growth HENDERSON, Nev., Nov. 19, 2024 /PRNewswire/ -- Research Solutions (NASDAQ:RSSS), a pioneer in scientific content delivery, today announced the appointment of Sefton Cohen as Chief Revenue Officer. Cohen brings over two decades of experience scaling high-growth SaaS companies and will play a pivotal role in accelerating Research Solutions' transformation from a scientific content provider to a comprehensive AI-enabled research intelligence platform. "Sefton's proven track record of driving triple-digit growth in the SaaS i

    11/19/24 8:00:00 AM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions Announces Acquisition of scite

    Transforms Search and Discovery Solutions for Researchers by Delivering Breakthrough AI Technology Adds $3.6 Million in Annualized Software Subscription Revenue HENDERSON, Nev., Nov. 27, 2023 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today announced their acquisition of scite, an award-winning search and discovery platform that leverages AI to increase the discoverability and evaluation of research.   RSSS) acquires scite, an award-winning search and discovery platform." alt="Research Solutions, Inc.

    11/27/23 8:00:00 AM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Research Solutions Reports Second Quarter Fiscal Year 2026 Results

    Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal second quarter ended December 31, 2025. Fiscal Second Quarter 2026 Summary (compared to prior-year quarter) Annual Recurring Revenue ("ARR") up 14% to $21.8 million, which includes approximately $15.3 million of B2B ARR and $6.4 million of B2C ARR.Forty-seven net new deployments in th

    2/12/26 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions to Announce Second Quarter Fiscal Year 2026 Results on Thursday, February 12, 2026

    HENDERSON, Nev., Jan. 29, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results for the second quarter fiscal 2026 ended December 31, 2025, on Thursday, February 12, 2026, at 5:00 p.m. ET. A press release containing the Company's financial results will be issued following the market close. Management will host the conference call, followed by a question-and-answer period. Date: Thursday, February 12, 2026Time: 5:00 p.m. ET (2:00 p.m. PT)Dial-in number: 1-203-5

    1/29/26 2:50:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions Announces CFO Transition

    HENDERSON, Nev., Dec. 11, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, announced that its Chief Financial Officer and Secretary, Bill Nurthen,  left the Company effective December 10, 2025 to pursue another opportunity. The Company has named its Controller, Dave Kutil, as interim Chief Financial Officer and Secretary. Mr. Kutil has served as Controller since joining the Company in 2023 and has more than 15 years of financial leadership experience. Prior to joining Research Solutions, he served as Controller for

    12/11/25 8:30:00 AM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    SEC Filings

    View All

    Research Solutions Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Research Solutions, Inc. (0001386301) (Filer)

    2/12/26 5:17:23 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Research Solutions, Inc. (0001386301) (Filer)

    12/11/25 8:35:59 AM ET
    $RSSS
    EDP Services
    Technology

    SEC Form 10-Q filed by Research Solutions Inc

    10-Q - Research Solutions, Inc. (0001386301) (Filer)

    11/14/25 4:01:14 PM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Financials

    Live finance-specific insights

    View All

    Research Solutions Reports Second Quarter Fiscal Year 2026 Results

    Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal second quarter ended December 31, 2025. Fiscal Second Quarter 2026 Summary (compared to prior-year quarter) Annual Recurring Revenue ("ARR") up 14% to $21.8 million, which includes approximately $15.3 million of B2B ARR and $6.4 million of B2C ARR.Forty-seven net new deployments in th

    2/12/26 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions to Announce Second Quarter Fiscal Year 2026 Results on Thursday, February 12, 2026

    HENDERSON, Nev., Jan. 29, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results for the second quarter fiscal 2026 ended December 31, 2025, on Thursday, February 12, 2026, at 5:00 p.m. ET. A press release containing the Company's financial results will be issued following the market close. Management will host the conference call, followed by a question-and-answer period. Date: Thursday, February 12, 2026Time: 5:00 p.m. ET (2:00 p.m. PT)Dial-in number: 1-203-5

    1/29/26 2:50:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions Reports First Quarter Fiscal Year 2026 Results

    Reports 21% Increase in ARR to $21.3 Million, Strong Growth in Net Income, Adjusted EBITDA and Operating Cash Flow HENDERSON, Nev., Nov. 13, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal first quarter ended September 30, 2025. Fiscal First Quarter 2026 Summary (compared to prior-year quarter) Annual Recurring Revenue ("ARR") up 21% to $21.3 million, which includes approximately $14.8 million of B2B recurring revenue and $6.5 million of B2C recurring revenue.  Net B2B ARR

    11/13/25 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Research Solutions Inc

    SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)

    12/9/24 5:34:36 PM ET
    $RSSS
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Research Solutions Inc

    SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)

    12/5/24 3:54:23 PM ET
    $RSSS
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Research Solutions Inc

    SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)

    11/19/24 4:40:24 PM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO & Secretary Kutil David was granted 30,000 shares and covered exercise/tax liability with 758 shares (SEC Form 4)

    4 - Research Solutions, Inc. (0001386301) (Issuer)

    12/22/25 9:14:39 PM ET
    $RSSS
    EDP Services
    Technology

    SEC Form 3 filed by new insider Kutil David

    3 - Research Solutions, Inc. (0001386301) (Issuer)

    12/22/25 9:12:51 PM ET
    $RSSS
    EDP Services
    Technology

    SEC Form 4 filed by Director Gayron Kenneth L

    4 - Research Solutions, Inc. (0001386301) (Issuer)

    12/16/25 6:01:31 PM ET
    $RSSS
    EDP Services
    Technology